September 2016

Newsletter-Banner

NIH Award Expands Landmark Alzheimer’s Biomarker Study

The National Institutes of Health (NIH) has announced that the Alzheimer’s Disease Neuroimaging Initiative (ADNI) will receive an award of approximately $40 million over the next five years. ADNI’s new launch, called ADNI3, will use innovative technologies in brain imaging and develop new ways to speed clinical trials by providing researchers with the biomarkers needed to detect and track the progression of Alzheimer’s disease. To learn more, go here.

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16 

Mark your calendars! ACT-AD’s Ninth Annual FDA/AD Allies Meeting is set for Wednesday, November 16, 2016, at the Bethesda North Marriott Hotel and Conference Center (5701 Marinelli Road, North Bethesda, Maryland, 20852). Get more information here.

What’s New at Anavex/An Update 

Last year, we featured a Q & A with CEO Christopher U. Missling, Ph.D., from Anavex Life Sciences Corp. Anavex is a biopharmaceutical company based in New York City and one of ACT-AD’s sponsors. We recently had the opportunity to interview the team at Anavex to get an update. To read the latest Q & A, go here.

ACT-AD Executive Director to Speak at BIO’s Patient & Health Advocacy Summit

ACT-AD Executive Director Cynthia A. Bens will serve as a panelist for “PDUFA VI and the Patient Voice in Drug Development: What’s Next” during BIO’s Patient & Health Advocacy Summit. The event takes place November 3-4 in Washington, D.C. More information about the summit can be found here.

Alzheimer’s Foundation of America Offers Free Webinar on Dementia Related Topics

The Alzheimer’s Foundation of America’s (AFA) Care Connection is a monthly webinar that allows caregivers and professionals the opportunity to learn more about dementia related topics and receive support, while connecting with others in the community. The webinars take place on the 2nd Thursday of each month from 1 p.m. to 2 p.m. To learn about upcoming Care Connection webinars, go here.

The 13th International Conference on Alzheimer’s and Parkinson’s Disease Registration Deadline/December 14

Save the date! AD/PD™ 2017 takes place March 29 to April 2, 2017 in Vienna, Austria. The conference brings together clinical investigators, basic scientists, established investigators, and young talents. To learn more about the conference, go here.